subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772

object_name: Alzheimer disease

tested_intervention: unsure


subject: CHEBI:77260

subject_name: Omeprazole

object_name: Huntington disease


subject: CHEBI:77260


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: heart valve disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: Sepsis

tested_intervention: yes


subject: CHEBI:135915

object_name: Sepsis, CTCAE


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Chemotherapy induced neutropenia


subject: PUBCHEM.COMPOUND:18943906

subject_name: Ibuprofen Ibuprofen Ibuprofen

object_name: Drug Interactions


subject: CHEBI:47835

subject_name: levibuprofen


subject: CHEBI:28830

subject_name: Chlorambucil

object_name: MALT lymphoma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Other Dermatology or Skin, CTCAE


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: dental caries


subject: PUBCHEM.COMPOUND:6912

object_name: Dental Caries, CTCAE


subject: PUBCHEM.COMPOUND:6912

object_name: infectious disease


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: ulcerative colitis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:34ZKU73FU3

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: biliary tract cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: telangiectasis


subject: UNII:2S9ZZM9Q9V

object_name: Cutaneous telangiectasia


subject: CHEBI:68595

subject_name: Telaprevir

object_name: Hepatic impairment


subject: PR:000002082

subject_name: receptor tyrosine-protein kinase erbB-2

object_name: breast neoplasm


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: PUBCHEM.COMPOUND:11963629

subject_name: ferryl iron

object_name: iron deficiency anemia


subject: UMLS:C5419095

subject_name: 4-Iodophenylalanine I-131

object_name: glioblastoma


subject: UMLS:C5419095

object_name: Childhood Glioblastoma


subject: UMLS:C5419095

object_name: adult glioblastoma


subject: UMLS:C5419095

object_name: Brain Stem Glioblastoma


subject: UMLS:C5419095

object_name: glioma susceptibility 1


subject: UMLS:C5419095

object_name: neoplastic syndrome


subject: UMLS:C5419095

object_name: neoplasm


subject: UMLS:C5419095

object_name: neoplastic disease or syndrome


subject: UMLS:C5399992

object_name: Myelodysplasia


subject: UMLS:C5399992

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5399992

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5399992

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5399992

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C5399992

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5399992

object_name: myeloproliferative neoplasm


subject: UMLS:C5399992

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: brain cancer


subject: CHEBI:172923

object_name: brain neoplasm


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: UMLS:C4085979

object_name: esophageal disorder


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:137706467

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:137706467

object_name: salivary gland carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: salivary gland cancer


subject: PUBCHEM.COMPOUND:137706467

object_name: tumor of salivary gland


subject: PUBCHEM.COMPOUND:137706467

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: prostate disorder


subject: PUBCHEM.COMPOUND:137706467

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:137706467

object_name: salivary duct carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: adrenal cortex carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: adenoid cystic carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: Neoplasms by Histologic Type


subject: PUBCHEM.COMPOUND:137706467

object_name: Benign acinar cell tumor


subject: PUBCHEM.COMPOUND:137706467

object_name: Acinar cell tumor


subject: PUBCHEM.COMPOUND:137706467

object_name: acinar cell carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: mucoepidermoid carcinoma


subject: PUBCHEM.COMPOUND:137706467

object_name: male reproductive system neoplasm


subject: PUBCHEM.COMPOUND:137706467

object_name: male reproductive organ cancer


subject: PUBCHEM.COMPOUND:137706467

object_name: Neoplasm of the genitourinary tract


subject: PUBCHEM.COMPOUND:137706467

object_name: cancer


subject: PUBCHEM.COMPOUND:137706467

object_name: neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: intrahepatic cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:31355

object_name: Childhood Extragonadal Malignant Germ Cell Tumor


subject: CHEBI:31355

object_name: Childhood Malignant Ovarian Germ Cell Tumor


subject: CHEBI:31355

object_name: Childhood Extracranial Germ Cell Tumor


subject: CHEBI:31355

object_name: Childhood Malignant Testicular Germ Cell Tumor


subject: CHEBI:31355

object_name: Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor


subject: CHEBI:31355

object_name: Testicular Mixed Choriocarcinoma and Yolk Sac Tumor


subject: CHEBI:31355

object_name: Testicular Mixed Choriocarcinoma and Embryonal Carcinoma


subject: CHEBI:31355

object_name: testicular yolk sac tumor


subject: CHEBI:31355

object_name: ovarian yolk sac tumor


subject: CHEBI:31355

object_name: testicular embryonal carcinoma


subject: CHEBI:31355

object_name: ovarian embryonal carcinoma


subject: CHEBI:31355

object_name: choriocarcinoma of testis


subject: CHEBI:31355

object_name: choriocarcinoma of ovary


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: Testis cancer recurrent


subject: UNII:PVI5M0M1GW

object_name: Recurrent Ovarian Germ Cell Tumor


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C5907921

subject_name: Anti-CD19/Anti-CD3/Anti-CD28 Trispecific Antibody CC312

object_name: autoimmune hemolytic anemia


subject: UMLS:C5907921

object_name: autoimmune thrombocytopenia


subject: UMLS:C5907921

object_name: EXCESS LMW-DNA


subject: UMLS:C5907921

object_name: rheumatoid arthritis


subject: UMLS:C0876064

subject_name: Lantus

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0876064

object_name: type 1 diabetes mellitus


subject: UNII:41XGO0VS1U

object_name: Cervix carcinoma recurrent


subject: UNII:41XGO0VS1U

object_name: Metastatic Cervical Carcinoma


subject: UNII:41XGO0VS1U

object_name: adverse effect


subject: UNII:41XGO0VS1U

object_name: Adverse effects


subject: UNII:41XGO0VS1U

object_name: Adverse reactions


subject: UMLS:C4727698

subject_name: Miptenalimab

object_name: neoplasm


subject: CHEBI:63577

subject_name: Lamivudine

object_name: liver cancer


subject: CHEBI:63577

object_name: liver neoplasm


subject: CHEBI:63577

object_name: Adult Liver Carcinoma


subject: CHEBI:59902

subject_name: ENTECAVIR


subject: CHEBI:59902


subject: CHEBI:59902


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: CHEBI:473990


subject: CHEBI:64045

subject_name: Amisulpride

object_name: post operative nausea and vomiting


subject: CHEBI:3814

subject_name: Colestipol

object_name: Hypercholesterolemia


subject: CHEBI:3814

object_name: hyperlipidemia


subject: CHEBI:3814

object_name: hyperlipoproteinemia


subject: CHEBI:3814

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:3814

object_name: Serum lipids high (finding)


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:17154


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:90488848


subject: GTOPDB:1331

subject_name: ACTH


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: CHEBI:3892

subject_name: Corticotropin


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UMLS:C1328139


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C0070319

subject_name: Cytochrome P-450 CYP2B1

object_name: hepatitis C


subject: UMLS:C0070319

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:66621102


subject: CHEBI:139019

subject_name: AZD1979 oxetane hydrolysis product

object_name: defect; postural


subject: CHEBI:175692

subject_name: 4-Hydroxyestrone sulfate


subject: CHEBI:140152

subject_name: cyclosporin A metabolite M1


subject: CHEBI:51079


subject: CHEBI:145218


subject: PUBCHEM.COMPOUND:75053179


subject: CHEBI:165221

subject_name: Desmetramadol


subject: UniProtKB:P15379-3

subject_name: CD44 antigen isoform 12 (mouse)


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: kidney disorder


subject: CHEBI:48390

object_name: impaired renal function disease


subject: UMLS:C5417984

subject_name: MEK Inhibitor HL-085

object_name: Adult Solid Neoplasm


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: Multiple sclerosis relapse


subject: UMLS:C2934225


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:114785

subject_name: Erlotinib

object_name: stage IIA non-small cell lung cancer


subject: CHEBI:114785

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: CHEBI:114785

object_name: stage IIB non-small cell lung cancer


subject: CHEBI:114785

object_name: stage IB non-small cell lung cancer


subject: MESH:C116580

subject_name: fructooligosaccharide

object_name: Overweight and obesity


subject: CHEBI:27082

subject_name: trehalose

object_name: acute coronary syndrome


subject: UMLS:C4527158

object_name: Advanced breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2109406

subject_name: PATRITUMAB

object_name: head and neck neoplasm


subject: UMLS:C3888263


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Distributive Shock Related to COVID-19


subject: PUBCHEM.COMPOUND:25476

object_name: Distributive shock


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: Familial hypercholesterolemia - heterozygous


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: Crohn disease


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: follicular lymphoma


subject: CHEBI:46195

object_name: marginal zone lymphoma


subject: CHEBI:46195

object_name: MALT lymphoma


subject: CHEBI:46195

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:46195

object_name: B-cell neoplasm


subject: CHEBI:46195

object_name: mantle cell lymphoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: GTOPDB:12652

subject_name: magrolimab


subject: GTOPDB:12652


subject: GTOPDB:12652


subject: GTOPDB:12652


subject: GTOPDB:12652


subject: GTOPDB:12652


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:133021

subject_name: Venetoclax


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Idiopathic osteoarthritis


subject: UNII:6XC1PAD3KF

object_name: Primary osteoarthritis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UNII:090IP5RV8F

subject_name: Omadacycline

object_name: infectious disease


subject: UMLS:C2003425

object_name: bipolar I disorder


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: type 1 diabetes mellitus


subject: CHEBI:135285

object_name: Diabetes, Autoimmune


subject: CHEBI:92769

subject_name: Iobenguane

object_name: carcinoid tumor


subject: CHEBI:92769

object_name: familial medullary thyroid carcinoma


subject: CHEBI:92769

object_name: medullary thyroid gland carcinoma


subject: CHEBI:92769

object_name: paraganglioma


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED

object_name: methamphetamine dependence


subject: CHEBI:4469

subject_name: dexamfetamine


subject: CHEBI:9356

subject_name: Sultopride

object_name: Treatment Resistant Disorders


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:3766

subject_name: Clozapine


subject: MESH:C000718012

subject_name: sucrosomial iron

object_name: celiac disease


subject: MESH:C000718012

object_name: iron deficiency anemia


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: CHEBI:32682

subject_name: L-argininium

object_name: cancer


subject: CHEBI:32682

object_name: neoplasm


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: UMLS:C3275038

subject_name: COMBIG-DC

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C3275038

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C0376659

subject_name: Cancer Vaccines


subject: UMLS:C0376659


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: familial cold autoinflammatory syndrome


subject: CHEBI:231683


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:6129

subject_name: Ketorolac

object_name: periodontitis, chronic, adult


subject: CHEBI:6129

object_name: chronic periodontitis


subject: CHEBI:94187

subject_name: Givinostat

object_name: juvenile idiopathic arthritis


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: hypertension


subject: PUBCHEM.COMPOUND:91973920

object_name: Hypertension, CTCAE


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: MESH:D056604


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: DRUGBANK:DB16606


subject: CHEBI:229660

subject_name: zilucoplan sodium

object_name: myasthenia gravis


subject: CHEBI:229660

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C5881693

subject_name: Zilbrysq


subject: UMLS:C5881693


subject: CHEBI:41139

subject_name: BETAINE


subject: CHEBI:10023

subject_name: Voriconazole

object_name: candidemia


subject: GTOPDB:13723

object_name: long COVID-19


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: UNII:DPT0O3T46P

object_name: Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified


subject: UNII:DPT0O3T46P

object_name: Refractory Hepatosplenic T-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: anaplastic large cell lymphoma


subject: UNII:DPT0O3T46P

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: UNII:DPT0O3T46P

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: UNII:DPT0O3T46P

object_name: Intestinal T-cell lymphoma refractory


subject: UNII:DPT0O3T46P

object_name: Recurrent Hepatosplenic T-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: UNII:DPT0O3T46P

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: subcutaneous panniculitis-like T-cell lymphoma


subject: UNII:DPT0O3T46P

object_name: Mycosis fungoides refractory


subject: UNII:DPT0O3T46P

object_name: Intestinal T-cell lymphoma recurrent


subject: UNII:DPT0O3T46P

object_name: Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Mycosis fungoides recurrent


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: CHEBI:71223

object_name: Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:71223

object_name: Refractory Hepatosplenic T-Cell Lymphoma


subject: CHEBI:71223

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:71223

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:71223

object_name: anaplastic large cell lymphoma


subject: CHEBI:71223

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: CHEBI:71223

object_name: Follicular lymphoma refractory


subject: CHEBI:71223

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: CHEBI:71223

object_name: Intestinal T-cell lymphoma refractory


subject: CHEBI:71223

object_name: Recurrent Hepatosplenic T-Cell Lymphoma


subject: CHEBI:71223

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: CHEBI:71223

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:71223

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:71223

object_name: subcutaneous panniculitis-like T-cell lymphoma


subject: CHEBI:71223

object_name: Mycosis fungoides refractory


subject: CHEBI:71223

object_name: Intestinal T-cell lymphoma recurrent


subject: CHEBI:71223

object_name: Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma


subject: CHEBI:71223

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:71223

object_name: Follicular lymphoma recurrent


subject: CHEBI:71223

object_name: Mycosis fungoides recurrent


subject: UMLS:C4721816

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C4721816

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C4721816

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C4721816

object_name: Myelodysplasia


subject: CHEBI:194507

object_name: Inflammatory Response


subject: CHEBI:194507

object_name: Vasopressin causing adverse effects in therapeutic use


subject: CHEBI:194507

object_name: colon cancer liver metastasis


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:8230

subject_name: Argipressin


subject: PUBCHEM.COMPOUND:8230


subject: PUBCHEM.COMPOUND:8230


subject: UMLS:C1527128

subject_name: Recombinant Vasopressin


subject: UMLS:C1527128


subject: UMLS:C1527128


subject: UMLS:C0003779

subject_name: argipressin


subject: UMLS:C0003779


subject: UMLS:C0003779


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:53477739


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: hypertension


subject: CHEBI:8093

object_name: Hypertension, CTCAE


subject: CHEBI:8093

object_name: essential hypertension, genetic


subject: CHEBI:8093

object_name: essential hypertension


subject: CHEBI:9728

subject_name: Trimethaphan


subject: CHEBI:9728


subject: UMLS:C2746145

subject_name: Vpriv

object_name: Gaucher disease type I


subject: CHEBI:50438

subject_name: Phenprocoumon

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:50438

object_name: Deep venous thrombosis


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEMBL.COMPOUND:CHEMBL2108918

subject_name: CHAMOMILE

object_name: blood coagulation disease


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Medication interaction potentiation


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: UNII:884KT10YB7

object_name: coronary artery disorder


subject: UNII:884KT10YB7

object_name: coronary atherosclerosis


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:53248

subject_name: Povidone

object_name: adenoviral keratoconjunctivitis


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: colorectal cancer


subject: UNII:5S371K6132

object_name: colorectal carcinoma


subject: UNII:5S371K6132

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:22023730

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:22023730

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:22023730

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:22023730

object_name: Maternity blues


subject: PUBCHEM.COMPOUND:22023730

object_name: Postpartum blues


subject: PUBCHEM.COMPOUND:22023730

object_name: puerperal disorder


subject: PUBCHEM.COMPOUND:22023730

object_name: progressive pseudorheumatoid arthropathy of childhood


subject: PUBCHEM.COMPOUND:22023730

object_name: Atypical behavior


subject: PUBCHEM.COMPOUND:22023730

object_name: pregnancy disorder


subject: PUBCHEM.COMPOUND:22023730

object_name: psychosis


subject: PUBCHEM.COMPOUND:22023730

object_name: mental disorder


subject: PUBCHEM.COMPOUND:22023730

object_name: psychiatric disorder


subject: PUBCHEM.COMPOUND:22023730

object_name: mood disorder


subject: CHEBI:8093

object_name: Anaesthetic complication spinal


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: lung neoplasm


subject: UNII:15C2VL427D

object_name: lung disorder


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Advanced cancer


subject: PR:000017019

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:50858

subject_name: corticosteroid

object_name: osteoarthritis, knee


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Childhood Breast Carcinoma


subject: CHEBI:9943

object_name: breast carcinoma


subject: CHEBI:9943

object_name: breast cancer


subject: MESH:C000730795

object_name: adverse effect to anesthesia


subject: MESH:C000730795

object_name: biliary tract disorder


subject: UMLS:C0251564

subject_name: Pulmozyme

object_name: cystic fibrosis


subject: CHEBI:231350

subject_name: Pacritinib

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5959215

subject_name: Anti-nectin-4/MMAE Antibody-drug Conjugate CRB-701

object_name: Adult Solid Neoplasm


subject: CHEBI:64312

subject_name: Memantine

object_name: Asperger syndrome


subject: GTOPDB:2479

subject_name: HCl

object_name: pervasive developmental disorder


subject: GTOPDB:2479

object_name: autism


subject: GTOPDB:2479


subject: GTOPDB:2479

object_name: autism spectrum disorder


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C1512523


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: UMLS:C0443985


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: CHEBI:17883


subject: CHEBI:17883


subject: UMLS:C4733615

object_name: Solid Neoplasm


subject: UMLS:C4733615

object_name: Homologous Recombination Repair Gene Mutation


subject: UMLS:C4733615

object_name: Homologous Recombination Deficiency


subject: UMLS:C1099324

subject_name: Thrombin-JMI

object_name: Epistaxis, CTCAE


subject: UMLS:C1099324

object_name: Epistaxis


subject: UMLS:C2266918

subject_name: Platinum-based Drug [EPC]

object_name: neoplasm of esophagus


subject: CHEBI:27385

subject_name: carbon tetrachloride

object_name: Helicobacter pylori infection


subject: PUBCHEM.COMPOUND:108142

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:BHB013S3MO

subject_name: SARCNU


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Malignant Solid Neoplasm


subject: CHEBI:45716

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:45716

object_name: clear cell renal carcinoma


subject: CHEBI:45716

object_name: renal cell adenocarcinoma


subject: CHEBI:45716

object_name: renal cell carcinoma


subject: CHEBI:68595

subject_name: Telaprevir

object_name: liver failure


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:68534

object_name: T-Cell Lymphoma


subject: CHEBI:68534

object_name: diffuse large B-cell lymphoma


subject: CHEBI:68534

object_name: endometrial cancer


subject: CHEBI:68534

object_name: uterine corpus cancer


subject: CHEBI:68534

object_name: endometrial carcinoma


subject: CHEBI:68534

object_name: Ovarian clear cell carcinoma


subject: CHEBI:68534

object_name: ovarian clear cell cancer


subject: CHEBI:68534

object_name: malignant mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL5095231

subject_name: TULMIMETOSTAT


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231

object_name: Metastatic castration-resistant prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231

object_name: castration-resistant prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: CHEMBL.COMPOUND:CHEMBL5095231


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: UNII:OUQ4N85Z0B


subject: PUBCHEM.COMPOUND:70669253

object_name: rheumatoid arthritis


subject: UMLS:C4045777


subject: CHEBI:75551


subject: CHEBI:4445

subject_name: Desflurane

object_name: Surgical procedure finding


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Nausea and vomiting


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Refractory acute myeloid leukemia


subject: GTOPDB:8313

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:23965

subject_name: estradiol

object_name: Postmenopausal depression


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: PUBCHEM.COMPOUND:432620

subject_name: Chestanin

object_name: pain agnosia


subject: PUBCHEM.COMPOUND:432620

object_name: Pain insensitivity


subject: CHEBI:65415

subject_name: Antroquinonol

object_name: atopic eczema


subject: CHEBI:6121

subject_name: Ketamine

object_name: brain neoplasm


subject: CHEBI:6121

object_name: epilepsy


subject: CHEBI:73604

subject_name: Lys-Gly


subject: PUBCHEM.COMPOUND:72455102

subject_name: Vorapaxar

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:72455102

object_name: coronary atherosclerosis


subject: UMLS:C5854498

subject_name: Recombinant Newcastle Disease Virus-encoding Interleukin-12 V938

object_name: Neoplasm Metastasis


subject: CHEBI:3757

subject_name: Clonidine

object_name: Arrhythmia


subject: UMLS:C3827137

subject_name: mRNA-derived Prostate Cancer Vaccine CV9104

object_name: prostate carcinoma


subject: UMLS:C3827137

object_name: prostate cancer


subject: CHEBI:78825

subject_name: Avutometinib

object_name: non-small cell lung carcinoma


subject: CHEBI:78825

object_name: KRAS Activating Mutation


subject: CHEBI:178199

subject_name: Sotorasib


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UMLS:C1738018

subject_name: INJECTION, DECITABINE, 1 MG ADMINISTERED

object_name: Myelodysplasia


subject: UMLS:C1738018

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1738018

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1738018

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:914032762Y

subject_name: PENTOSAN POLYSULFATE SODIUM

object_name: prostatitis


subject: CHEBI:184555

subject_name: Xylan Sulfate


subject: CHEBI:6801

subject_name: Metformin

object_name: lung cancer


subject: CHEBI:6801

object_name: lung neoplasm


subject: CHEBI:6801

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: rectal neoplasm


subject: CHEBI:63450

subject_name: Masitinib

object_name: chronic progressive multiple sclerosis


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: PUBCHEM.COMPOUND:54675783


subject: PUBCHEM.COMPOUND:54675783


subject: CHEMBL.COMPOUND:CHEMBL4298036

subject_name: CURCUMINOIDS

object_name: lichen planus, oral


subject: UMLS:C4086228

subject_name: Curcuminoid


subject: CHEMBL.COMPOUND:CHEMBL2108234

subject_name: COD LIVER OIL


subject: CHEMBL.COMPOUND:CHEMBL2108234

object_name: respiratory tract infectious disorder


subject: UMLS:C1576750

subject_name: BANABA

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1576750

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:131952892

subject_name: Lutetium (177Lu) oxodotreotide

object_name: adrenal gland pheochromocytoma


subject: PUBCHEM.COMPOUND:131952892

object_name: pheochromocytoma


subject: PUBCHEM.COMPOUND:131952892

object_name: paraganglioma


subject: UNII:N3858377KC


subject: UNII:N3858377KC


subject: UNII:N3858377KC


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: Ataxia


subject: CHEBI:31632

object_name: atactic disorder


subject: CHEBI:31632

object_name: Ataxia as late effect of cerebrovascular disease


subject: CHEBI:31632

object_name: Dyssynergia


subject: CHEBI:31632

object_name: Ataxia, CTCAE_5


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


subject: UMLS:C1145196


subject: UMLS:C1145196


subject: UMLS:C1145196


subject: UMLS:C1145196


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:61033


subject: CHEBI:151129

subject_name: DABCO

object_name: hyperlipidemia


subject: PR:000030646

subject_name: NALCN channel auxiliary factor 2


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: UMLS:C4722596

subject_name: pTVG-AR Vaccine

object_name: prostate carcinoma


subject: UMLS:C4722596

object_name: prostate cancer


subject: UMLS:C4722596

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4722596

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4722596

object_name: Embolism, Tumor


subject: UMLS:C4722596

object_name: Neoplasm Metastasis


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:50730

subject_name: Montelukast

object_name: diabetic kidney disease


subject: UMLS:C5691169

subject_name: Dimolegin


subject: UMLS:C5691169

object_name: venous thromboembolism


subject: UMLS:C5691169

object_name: thrombophilia due to thrombin defect


subject: CHEBI:28179

subject_name: benzamide

object_name: Parkinson disease


subject: CHEBI:27796

subject_name: Trimethobenzamide


subject: UNII:7DVX185FLQ

subject_name: Iomazenil

object_name: Cognitive impairment


subject: CHEBI:135665

subject_name: IOMAZENIL I-123


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Consent Type - Hysterectomy


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:77590

subject_name: Armodafinil

object_name: narcolepsy


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Barrett esophagus


subject: UMLS:C4329329

object_name: Cervix carcinoma recurrent


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C5666992

subject_name: PI3K-gamma Inhibitor ZX-4081

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Ewing sarcoma


subject: UNII:YW45RY9QD4

object_name: sclerosing cholangitis


subject: UNII:YW45RY9QD4

object_name: primary sclerosing cholangitis


subject: UMLS:C0284216


subject: UMLS:C0284216


subject: CHEBI:9332

subject_name: Sulfamethoxazole

object_name: pyelonephritis


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Cesarean scar pregnancy


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: PUBCHEM.COMPOUND:57320831

subject_name: Urodilatin

object_name: ADHF


subject: GTOPDB:8446

subject_name: ularitide


subject: UMLS:C0077910

subject_name: Ularitide


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: ocular melanoma


subject: UMLS:C3534685

object_name: uveal melanoma


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UMLS:C5203181


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: neuralgia


subject: CHEBI:27300

object_name: Neuropathic pain


subject: CHEBI:16899

subject_name: Mannitol

object_name: cerebral malaria


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Post-Operative Pain


subject: CHEBI:67271

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:67271

object_name: Carcinoma breast stage IV


subject: CHEBI:67271

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:67271

object_name: Breast cancer recurrent


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Progesterone Receptor Negative


subject: CHEBI:49603

object_name: Estrogen Receptor Negative


subject: CHEBI:2549

subject_name: Albuterol

object_name: Bronchospasm


subject: CHEBI:2549

object_name: Bronchoconstriction


subject: CHEBI:2549

object_name: Bronchospasm, CTCAE


subject: CHEBI:72296

subject_name: Apixaban

object_name: Neck Carcinoma


subject: CHEBI:72296

object_name: head and neck neoplasm


subject: CHEBI:72296

object_name: head and neck cancer


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Neonatal hypoglycemia


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Inflammation


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Premature birth


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: atopy


subject: UMLS:C4706052

object_name: rheumatoid arthritis


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: epidermolysis bullosa


subject: UMLS:C3884993

subject_name: AMG 181

object_name: ulcerative colitis


subject: UMLS:C3884993

object_name: inflammatory bowel disease 1


subject: UNII:9RL37ZZ665

subject_name: Orantinib

object_name: liver carcinoma


subject: UMLS:C2001702

subject_name: TSU 68


subject: CHEBI:44915

subject_name: Propofol

object_name: traumatic encephalopathy


subject: CHEBI:44915

object_name: traumatic brain injury


subject: CHEBI:31263

subject_name: Bentiromide

object_name: Chronic pelvic pain syndrome


subject: CHEBI:62880

subject_name: Veliparib

object_name: Solid Neoplasm


subject: UMLS:C1831920

subject_name: ABT 888


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:4479094

object_name: prostate cancer


subject: CHEBI:64816

object_name: optic nerve glioma


subject: CHEBI:64816

object_name: childhood pilocytic astrocytoma


subject: CHEBI:64816

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:64816

object_name: Spongioblastoma


subject: CHEBI:64816

object_name: oligoastrocytoma


subject: CHEBI:64816

object_name: glioma susceptibility 1


subject: CHEBI:64816

object_name: adult oligodendroglioma


subject: CHEBI:64816

object_name: oligodendroglioma


subject: CHEBI:64816

object_name: childhood oligodendroglioma


subject: CHEBI:64816

object_name: mixed glioma


subject: CHEBI:64816

object_name: Adult Mixed Glioma


subject: CHEBI:64816

object_name: Childhood Mixed Glioma


subject: CHEBI:64816

object_name: glioma


subject: CHEBI:64816

object_name: Childhood Astrocytoma


subject: CHEBI:64816

object_name: astrocytic tumor


subject: CHEBI:64816

object_name: astrocytoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:4911

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:4911

object_name: anaplastic astrocytoma


subject: CHEBI:4911

object_name: childhood pilocytic astrocytoma


subject: CHEBI:4911

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:4911

object_name: Spongioblastoma


subject: CHEBI:4911

object_name: oligoastrocytoma


subject: CHEBI:4911

object_name: adult oligodendroglioma


subject: CHEBI:4911

object_name: oligodendroglioma


subject: CHEBI:4911

object_name: childhood oligodendroglioma


subject: CHEBI:4911

object_name: mixed glioma


subject: CHEBI:4911

object_name: Adult Mixed Glioma


subject: CHEBI:4911

object_name: Childhood Mixed Glioma


subject: CHEBI:4911

object_name: glioma


subject: CHEBI:4911

object_name: malignant glioma


subject: CHEBI:4911

object_name: Childhood Astrocytoma


subject: CHEBI:4911

object_name: astrocytic tumor


subject: CHEBI:4911

object_name: astrocytoma


subject: UMLS:C0718234

subject_name: Acthar

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:2735

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:2735

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:2735

object_name: Pulmonary function (finding)


subject: PUBCHEM.COMPOUND:2735

object_name: pneumonia


subject: PUBCHEM.COMPOUND:2735

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: asthma


subject: GTOPDB:10492

subject_name: envafolimab

object_name: colorectal neoplasm


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: cystic fibrosis


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:64816

object_name: Relapse multiple myeloma


subject: CHEBI:64816

object_name: Plasma cell myeloma recurrent


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: RXCUI:2648470

subject_name: mometasone furoate Nasal Spray

object_name: Large adenoids


subject: RXCUI:2648470

object_name: Nasal congestion


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: metastatic colorectal cancer


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:6456

subject_name: Lidocaine

object_name: cervical cancer


subject: CHEBI:6456

object_name: cervical carcinoma


subject: CHEBI:6456

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:6456

object_name: Embolism, Tumor


subject: CHEBI:6456

object_name: Neoplasm Metastasis


subject: CHEBI:93862

object_name: molluscum contagiosum


subject: CHEBI:64213

subject_name: Cantharidin


subject: CHEBI:6456

object_name: Abdominal pain


subject: CHEBI:6456

object_name: Abdominal Pain, CTCAE


subject: CHEBI:6456

object_name: malabsorption syndrome


subject: CHEBI:6456

object_name: dyspepsia


subject: CHEBI:6456

object_name: Dyspepsia, CTCAE


subject: CHEBI:2948

subject_name: Azathioprine

object_name: ulcerative colitis


subject: CHEBI:2948

object_name: Exacerbation of ulcerative colitis


subject: CHEBI:40279

subject_name: Allopurinol


subject: CHEBI:40279


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: heart failure


subject: PUBCHEM.COMPOUND:11306691

object_name: congestive heart failure


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:9907

subject_name: ursodiol

object_name: rhegmatogenous retinal detachment


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: coronary artery disorder


subject: UNII:PVI5M0M1GW

object_name: coronary atherosclerosis


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:68OJX9I7DT

object_name: Crohn disease


subject: UNII:824ZMS3BGL


subject: UMLS:C1101538


subject: UNII:T8B2ORP1DW

subject_name: Evinacumab


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C1611320

object_name: pulmonary hypertension


subject: UNII:7N13IK9LNH

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:7N13IK9LNH

object_name: Metastatic neuroendocrine carcinoma


subject: UNII:7N13IK9LNH

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Unresectable Neuroendocrine Carcinoma


subject: UNII:7N13IK9LNH

object_name: Metastatic Lung Small Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Unresectable Lung Small Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:7N13IK9LNH

object_name: Unresectable Malignant Solid Neoplasm


subject: DRUGBANK:DB19041

subject_name: Elimusertib


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:895VG117HN

subject_name: Celgosivir

object_name: dengue disease


subject: CHEBI:44915

subject_name: Propofol

object_name: Airway complication of anaesthesia


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: HIV infection


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C5391453

object_name: tuberculosis


subject: UMLS:C5391453


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Addictive stimulant use


subject: CHEBI:31236

object_name: Harmful pattern of use of stimulant


subject: CHEBI:31236

object_name: Schizophrenia and related disorders


subject: CHEBI:31236

object_name: stimulant use with stimulant-induced psychotic disorder


subject: CHEBI:82978

subject_name: paliperidone


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:63631

subject_name: Topiramate

object_name: Transformed migraine


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib

object_name: Childhood Solid Neoplasm


subject: UNII:0BSC3P4H5X

object_name: Adult Solid Neoplasm


subject: UNII:0BSC3P4H5X

object_name: Solid Neoplasm


subject: UMLS:C2981846


subject: UMLS:C2981846


subject: UMLS:C2981846


subject: GTOPDB:7431

subject_name: lorvotuzumab mertansine

object_name: nephroblastoma


subject: GTOPDB:7431

object_name: Wilms tumor


subject: GTOPDB:7431

object_name: childhood kidney Wilms tumor


subject: GTOPDB:7431

object_name: pulmonary blastoma


subject: GTOPDB:7431

object_name: pleuropulmonary blastoma


subject: GTOPDB:7431

object_name: DICER1 syndrome


subject: GTOPDB:7431

object_name: Recurrent Malignant Peripheral Nerve Sheath Tumor


subject: GTOPDB:7431

object_name: Synovial sarcoma recurrent


subject: GTOPDB:7431

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: GTOPDB:7431

object_name: Recurrent Rhabdomyosarcoma


subject: GTOPDB:7431

object_name: Neuroblastoma recurrent


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UNII:0IVD6ASY0W


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C2347419

object_name: Neoplasm Metastasis


subject: CHEBI:83766

subject_name: Olaparib


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: Acute Stroke


subject: CHEBI:15366

subject_name: Acetic acid

object_name: prostate carcinoma


subject: CHEBI:15366

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:4695

subject_name: Isosulfan blue

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:4695

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:4695

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:4695

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:4695

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:4695


subject: UNII:39N9K8S2A4

subject_name: isosulfan blue


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:O6L62LZJ0Q

object_name: endogenous depression


subject: UNII:O6L62LZJ0Q

object_name: major depressive disorder


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)

object_name: non-small cell lung carcinoma


subject: MESH:C000712049

object_name: carcinoma


subject: UMLS:C3658787


subject: CHEBI:6413

subject_name: Letrozole

object_name: Postmenopausal


subject: CHEBI:6413

object_name: osteoporosis


subject: CHEBI:6413

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:6413

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:6413

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: EBV Infection


subject: PUBCHEM.COMPOUND:137706467

object_name: X-linked lymphoproliferative syndrome


subject: PUBCHEM.COMPOUND:137706467

object_name: familial hemophagocytic lymphohistiocytosis type 1


subject: PUBCHEM.COMPOUND:137706467


subject: PUBCHEM.COMPOUND:137706467

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEMBL.COMPOUND:CHEMBL4594330

subject_name: DAXDILIMAB

object_name: lupus nephritis


subject: UMLS:C5420897

subject_name: Daxdilimab


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4507303

object_name: Childhood Breast Carcinoma


subject: UMLS:C4507303

object_name: breast carcinoma


subject: UMLS:C4507303

object_name: breast cancer


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Suicidal ideation


subject: UMLS:C2346514

object_name: Suicidal Ideation, CTCAE


subject: UMLS:C2346514

object_name: suicidal impulses


subject: UMLS:C2346514

object_name: Depressed mood


subject: UMLS:C2346514

object_name: Cancer patients and suicide and depression


subject: UMLS:C2346514

object_name: Depressed - symptom


subject: UMLS:C2346514

object_name: Depression, CTCAE


subject: CHEBI:132967

subject_name: Elbasvir

object_name: chronic kidney disease


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR


subject: CHEBI:132975

subject_name: Grazoprevir


subject: UNII:MZ37792Y8J

subject_name: Oprozomib

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C2984209


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic Ewing's Sarcoma


subject: CHEBI:4026

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:4026

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:4026

object_name: Metastatic malignant neoplasm to bone marrow


subject: CHEBI:4026

object_name: Peripheral neuroepithelioma of bone metastatic


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: peripheral primitive neuroectodermal tumor of soft tissues


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: CHEBI:2569

subject_name: Alfentanil

object_name: cancer


subject: CHEBI:2569

object_name: neoplasm


subject: CHEBI:27808

subject_name: Diamorphine


subject: CHEBI:27808


subject: CHEBI:6933

subject_name: Midodrine

object_name: hepatorenal syndrome


subject: CHEBI:7726

subject_name: octreotide


subject: UMLS:C3709450

subject_name: CALANUS OIL

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3709450


subject: UMLS:C3709450

object_name: Child attention deficit disorder


subject: UMLS:C0304450

subject_name: ANESTHETIC ADJUNCTS

object_name: aspiration pneumonia


subject: UMLS:C0304450

object_name: aspiration pneumonitis


subject: UMLS:C0304450

object_name: respiratory tract infectious disorder


subject: UMLS:C0304450

object_name: respiratory failure


subject: UMLS:C0304450

object_name: Respiratory Failure, CTCAE


subject: UMLS:C0304450

object_name: Bronchospasm


subject: UMLS:C0304450

object_name: Bronchoconstriction


subject: UMLS:C0304450

object_name: Bronchospasm, CTCAE


subject: UMLS:C0304450

object_name: pneumonitis


subject: UMLS:C0304450

object_name: Pneumonitis, CTCAE


subject: UMLS:C0304450

object_name: Atelectasis


subject: UMLS:C0304450

object_name: Atelectasis, CTCAE


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Inflammation


subject: PUBCHEM.COMPOUND:2735

object_name: malnutrition


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:135738

subject_name: Clevidipine

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:135738

object_name: Acute heart failure


subject: CHEBI:135738

object_name: Dyspnea


subject: CHEBI:135738

object_name: Dyspnea, CTCAE


subject: CHEBI:135738

object_name: cardiovascular surgery result: dyspnea


subject: GTOPDB:13624

subject_name: inclisiran

object_name: acute coronary syndrome


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: Mullerian mixed tumor of ovary


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: UMLS:C0054946

subject_name: CD20 Antigens

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C0054946

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C0054946

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C0054946

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C0054946

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C0054946

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UMLS:C0054946

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UMLS:C0054946

object_name: Refractory B-Cell Prolymphocytic Leukemia


subject: UMLS:C0054946

object_name: Recurrent B-Cell Prolymphocytic Leukemia


subject: UMLS:C0054946

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: UMLS:C0054946

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: UMLS:C0054946

object_name: Recurrent Indolent Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: Refractory Indolent Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: Refractory Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0054946

object_name: High grade B-cell lymphoma refractory


subject: UMLS:C0054946

object_name: High grade B-cell lymphoma recurrent


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1

object_name: Chronic lymphocytic leukaemia refractory


subject: PR:000001289

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PR:000001289

object_name: Acute lymphoblastic leukemia recurrent


subject: PR:000001289

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PR:000001289

object_name: Non-Hodgkin's lymphoma refractory


subject: PR:000001289

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: PR:000001289

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: PR:000001289

object_name: Refractory B-Cell Prolymphocytic Leukemia


subject: PR:000001289

object_name: Recurrent B-Cell Prolymphocytic Leukemia


subject: PR:000001289

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: PR:000001289

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: PR:000001289

object_name: Recurrent Indolent Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: Refractory Indolent Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: Refractory Childhood Non-Hodgkin Lymphoma


subject: PR:000001289

object_name: High grade B-cell lymphoma refractory


subject: PR:000001289

object_name: High grade B-cell lymphoma recurrent


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: neuroendocrine neoplasm


subject: UMLS:C3896806


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: retinitis pigmentosa


subject: CHEBI:28939

object_name: retinitis pigmentosa 1


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Parkinson disease


subject: PR:000005931


subject: UNII:T87K47QVF3

subject_name: SEFAXERSEN

object_name: IgA Nephropathy


subject: UMLS:C5908931

subject_name: Sefaxersen


subject: CHEBI:36386

subject_name: Dichloroacetic acid

object_name: head and neck squamous cell carcinoma


subject: CHEBI:28240

subject_name: dichloroacetate


subject: UMLS:C3896782

subject_name: Plectin-1 Targeting Agent PTP-01

object_name: pancreatic ductal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: respiratory failure


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: acute respiratory failure


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Poisoning by anticoagulant


subject: CHEMBL.COMPOUND:CHEMBL5314348


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:59173


subject: CHEBI:59173


subject: CHEBI:59173


subject: CHEBI:59173


subject: PUBCHEM.COMPOUND:3000

subject_name: Topisolon

object_name: Chronic small plaque psoriasis


subject: CHEBI:691037

subject_name: Desoximetasone


subject: UMLS:C1832016

object_name: colon carcinoma


subject: UMLS:C1832016

object_name: rectal carcinoma


subject: UMLS:C1832016

object_name: rectum adenocarcinoma


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: HIV infection


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: coronary artery disorder


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:132201704


subject: PUBCHEM.COMPOUND:3021749

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:GR88G0I6UL

subject_name: IPRATROPIUM


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage II Vulvar Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Vulvar Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Vulvar Cancer AJCC v8


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496


subject: CHEBI:7496

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: CHEBI:7496

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: CHEBI:7496

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:25476

object_name: chronic liver failure


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: GTOPDB:8002

subject_name: bavituximab

object_name: liver cancer


subject: GTOPDB:8002

object_name: liver neoplasm


subject: GTOPDB:8002

object_name: Adult Liver Carcinoma


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:4026

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:4026

object_name: Blasts 5 Percent or More of Bone Marrow Nucleated Cells


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:Q6C9WHR03O

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:Q6C9WHR03O

object_name: non-Hodgkin lymphoma


subject: UNII:Q6C9WHR03O

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:Q6C9WHR03O

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:Q6C9WHR03O

object_name: acute lymphoblastic leukemia


subject: UNII:Q6C9WHR03O

object_name: acute biphenotypic leukemia


subject: UNII:Q6C9WHR03O

object_name: Infant Acute Biphenotypic Leukemia


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O

object_name: Neoplasm, Residual


subject: UNII:Q6C9WHR03O

object_name: CD19 Positive


subject: CHEBI:87681

subject_name: Ranolazine

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:87681

object_name: metabolic syndrome X


subject: CHEBI:8207

subject_name: Pilocarpine

object_name: Neck Carcinoma


subject: CHEBI:8207

object_name: head and neck neoplasm


subject: CHEBI:8207

object_name: head and neck cancer


subject: CHEBI:8207

object_name: Oral Complication


subject: CHEBI:3219

subject_name: Bupropion

object_name: substance-related disorder


subject: UMLS:C1170011

subject_name: insulin aspart protamine, human

object_name: type 2 diabetes mellitus


subject: UMLS:C4331433

subject_name: Truncated Tissue Factor/NGR Peptide

object_name: lymphoma


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Advanced Malignant Solid Neoplasm


subject: GTOPDB:4942

object_name: Refractory Neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C5392068


subject: CHEBI:135915

subject_name: Thymalfasin


subject: CHEBI:135915


subject: PUBCHEM.COMPOUND:10198924

subject_name: CHOLINE BITARTRATE

object_name: Heart Disease Risk Factors


subject: CHEBI:16822

subject_name: choline sulfate


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: xeroderma pigmentosum


subject: UMLS:C0066889

subject_name: MT-I


subject: UMLS:C0021658

subject_name: Humulin N

object_name: Diabetes


subject: UMLS:C0021658

object_name: diabetes mellitus


subject: UMLS:C0021658

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0021658

object_name: type 1 diabetes mellitus


subject: DRUGBANK:DB18621

object_name: facioscapulohumeral muscular dystrophy 1


subject: DRUGBANK:DB18621

object_name: facioscapulohumeral muscular dystrophy


subject: DRUGBANK:DB18621

object_name: facioscapulohumeral muscular dystrophy 2


subject: DRUGBANK:DB18621

object_name: Landouzy-Dejerine syndrome


subject: UMLS:C5555561

subject_name: Anti-LAG-3 Monoclonal Antibody LBL-007

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5555561

object_name: Esophageal Squamous Cell Carcinoma by AJCC v8 Stage


subject: UMLS:C5555561

object_name: carcinoma of esophagus


subject: UMLS:C5555561

object_name: esophageal cancer


subject: UMLS:C5555561

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5555561

object_name: neoplasm of esophagus


subject: UMLS:C5854370

subject_name: Anti-CLDN18.2 Heavy Chain Antibody Fc Fusion Protein DR30303

object_name: digestive system cancer


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Parkinson disease


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Depressed mood


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Cancer patients and suicide and depression


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Depressed - symptom


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Depression, CTCAE


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Hypotension on induction


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:4887

subject_name: Ethosuximide

object_name: peripheral nervous system disorder


subject: CHEBI:4887

object_name: neuropathy


subject: CHEBI:4887

object_name: cancer


subject: CHEBI:4887

object_name: neoplasm


subject: GTOPDB:12690

subject_name: odronextamab

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: GTOPDB:12690

object_name: Diffuse large B-cell lymphoma recurrent


subject: GTOPDB:12690

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12690

object_name: High grade B-cell lymphoma refractory


subject: GTOPDB:12690

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: GTOPDB:12690

object_name: High grade B-cell lymphoma recurrent


subject: GTOPDB:12690

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: GTOPDB:12690

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: GTOPDB:12690

object_name: Refractory Grade 3b Follicular Lymphoma


subject: GTOPDB:12690

object_name: Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: GTOPDB:12690

object_name: Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: GTOPDB:12690

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UNII:8R5CM46UIO

subject_name: ODRONEXTAMAB


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UMLS:C3896743

subject_name: Odronextamab


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C5706413

subject_name: Cereblon Modulator BTX-1188

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706413

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5706413

object_name: acute myeloid leukemia


subject: UMLS:C5706413

object_name: non-Hodgkin lymphoma


subject: CHEBI:23965

subject_name: estradiol

object_name: Vasodilation disorder


subject: UNII:U946SH95EE

subject_name: Milk thistle

object_name: Hair-pulling


subject: UMLS:C0872906

subject_name: milk thistle seed extract


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Pain in lumbar spine


subject: CHEBI:41879

object_name: Low back pain


subject: CHEBI:41879

object_name: Lumbar radiculitis


subject: CHEBI:41879

object_name: LUMBAR SPINE DISC HERNIATION


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:75998

subject_name: Trametinib

object_name: plasma cell myeloma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: malignant glioma


subject: UMLS:C3827082


subject: UMLS:C3274746

subject_name: PVS-RIPO


subject: UMLS:C4305922

subject_name: LCP-AtorFen

object_name: inherited lipid metabolism disorder


subject: UMLS:C4305922

object_name: Dyslipidemia


subject: CHEBI:174615

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:174615


subject: CHEBI:174615

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:174615

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: CHEBI:174615

object_name: essential thrombocythemia


subject: CHEBI:174615

object_name: acquired polycythemia vera


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775

object_name: Myelofibrosis due to another disorder


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:90467376

object_name: cognitive disorder


subject: UniProtKB:P53767

subject_name: VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)

object_name: pancreatic neoplasm


subject: UniProtKB:P53767

object_name: exocrine pancreatic carcinoma


subject: UniProtKB:P53767

object_name: malignant pancreatic neoplasm


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2


subject: PR:000002112


subject: PR:000002112


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:17925

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:17925

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:33704

subject_name: Amino acid


subject: CHEBI:33704


subject: CHEBI:33704


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: CHEBI:18059

subject_name: lipid


subject: CHEBI:18059


subject: CHEBI:18059


subject: MESH:D008055

subject_name: Lipids


subject: MESH:D008055


subject: MESH:D008055


subject: PUBCHEM.COMPOUND:57748689

object_name: melanoma


subject: UNII:7M346920EV


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: bronchopulmonary dysplasia


subject: UNII:1C6V77QF41

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C5706492

subject_name: Anti-ENPP3/Anti-CD3 Bispecific Antibody XmAb819

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5706492

object_name: clear cell renal carcinoma


subject: CHEBI:229599

subject_name: Trofinetide

object_name: Rett syndrome


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Pilon fracture


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: bipolar disorder


subject: CHEBI:6456

subject_name: Lidocaine

object_name: colorectal carcinoma


subject: CHEBI:6456

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IB Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: stage IB cervical cancer


subject: PUBCHEM.COMPOUND:2767

object_name: stage III cervical cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Cervical carcinoma stage IIA


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Cervical Cancer AJCC v6


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Cervical carcinoma stage IIB


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: cervical squamous cell carcinoma


subject: UMLS:C2699969

subject_name: Topotecan Hydrochloride Liposomes


subject: UMLS:C2699969


subject: UMLS:C2699969

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UMLS:C2699969


subject: UMLS:C2699969

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C2699969


subject: UMLS:C2699969

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C2699969

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C2699969

object_name: Cervical carcinoma stage IVA


subject: UMLS:C2699969


subject: UMLS:C2699969


subject: UMLS:C2699969


subject: UMLS:C2699969

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UMLS:C2699969

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UMLS:C2699969


subject: UMLS:C2699969


subject: UMLS:C2699969

object_name: cervical adenocarcinoma


subject: UMLS:C2699969


subject: CHEBI:3023

subject_name: Benzbromarone

object_name: chronic kidney disease


subject: CHEBI:3023

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:3023

object_name: Abnormal renal physiology


subject: CHEBI:3023

object_name: Hyperuricemia


subject: CHEBI:3023

object_name: Hyperuricemia, CTCAE


subject: CHEBI:31596

subject_name: Febuxostat


subject: CHEBI:31596


subject: CHEBI:31596


subject: GTOPDB:8221

subject_name: epacadostat

object_name: Recurrent ovarian cancer


subject: GTOPDB:8221

object_name: ovarian clear cell cancer


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Iron deficiency


subject: CHEBI:131724

subject_name: iclaprim

object_name: Hospital acquired pneumonia


subject: CHEBI:131724

object_name: ventilator-associated pneumonia


subject: CHEBI:131724

object_name: Healthcare associated pneumonia


subject: CHEBI:131751

subject_name: Iclaprim


subject: CHEBI:131751


subject: CHEBI:131751


subject: CHEBI:135530

subject_name: Solifenacin

object_name: lower urinary tract symptom


subject: CHEBI:135530

object_name: bladder neck obstruction


subject: CHEBI:9398

subject_name: Tamsulosin


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Cirrhosis


subject: UNII:9U7D5QH5AE


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: head and neck neoplasm


subject: UNII:082285VIDF

object_name: squamous cell carcinoma


subject: UNII:082285VIDF

object_name: Neoplasm Metastasis


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18


subject: UNII:8MSY49469G


subject: UNII:8MSY49469G


subject: UMLS:C1506837

object_name: Childhood Breast Carcinoma


subject: UMLS:C1506837

object_name: breast carcinoma


subject: UMLS:C1506837

object_name: breast cancer


subject: PUBCHEM.COMPOUND:2767

object_name: oropharynx squamous cell carcinoma


subject: CHEBI:8494

subject_name: Propiverine hydrochloride

object_name: Urinary Urgency


subject: CHEBI:8493

subject_name: Propiverine


subject: UNII:DPT0O3T46P

object_name: anal canal cancer


subject: UNII:DPT0O3T46P

object_name: anal canal carcinoma


subject: UNII:DPT0O3T46P

object_name: HPV-associated cervical carcinoma


subject: UNII:DPT0O3T46P

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: CHEBI:93775

subject_name: Amethopterin

object_name: nephrotoxicity


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:83766

subject_name: Olaparib

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: Rash and Dermatitis Associated with Radiation Excluding Chemoradiation, CTCAE


subject: PUBCHEM.COMPOUND:71301229

object_name: radiation exposure measurement


subject: PUBCHEM.COMPOUND:71301229

object_name: rectal neoplasm


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: cervical carcinoma


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:45783

subject_name: Imatinib

object_name: seminoma


subject: CHEBI:45783

object_name: testis seminoma


subject: CHEBI:45783

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:45783

object_name: Stage II Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:45783

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:45783

object_name: Testis cancer recurrent


subject: CHEBI:45783

object_name: stage III testicular cancer


subject: CHEBI:45783

object_name: stage II testicular cancer


subject: CHEBI:45783

object_name: dysgerminoma of ovary


subject: CHEBI:229469

subject_name: Sulodexide

object_name: coronary microvascular disorder


subject: CHEBI:229469

object_name: Inflammation


subject: CHEBI:229469


subject: CHEBI:229469

object_name: Blood Clot


subject: CHEBI:229469

object_name: thrombosis


subject: CHEBI:229469

object_name: Thrombosis of blood vessel


subject: CHEBI:82717

subject_name: Tedizolid

object_name: Skin and subcutaneous tissue bacterial infections


subject: CHEBI:520985

subject_name: Almotriptan

object_name: sinusitis


subject: CHEBI:520985

object_name: Sinusitis, CTCAE


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: CHEBI:51209


subject: CHEBI:51209

object_name: migraine


subject: CHEBI:51209

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:71204

subject_name: bepotastine

object_name: Atopic rhinitis


subject: CHEBI:71204

object_name: Hay fever


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:72317

object_name: papillary renal cell carcinoma


subject: CHEBI:72317

object_name: chromophobe renal cell carcinoma


subject: CHEBI:72317

object_name: sarcomatoid renal cell carcinoma


subject: CHEBI:72317

object_name: Unclassified Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Renal Cell Carcinoma, Not Otherwise Specified


subject: CHEBI:72317

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:72317

object_name: renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions


subject: CHEBI:72317

object_name: malignant urinary system neoplasm


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Injury of kidney


subject: UMLS:C5392712

object_name: Hyperuricemia


subject: UMLS:C5392712

object_name: Hyperuricemia, CTCAE


subject: CHEBI:57986

object_name: Pathological Dilatation


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:63624

subject_name: Telbivudine

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:155510360

object_name: Drug-sensitive tuberculosis


subject: PUBCHEM.COMPOUND:155510360

object_name: pulmonary tuberculosis


subject: UNII:OYN1GF5B1M


subject: UNII:OYN1GF5B1M


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Gastrointestinal complication


subject: CHEBI:94518

object_name: Wound Infection


subject: CHEBI:94518

object_name: Wound Infection, CTCAE


subject: CHEBI:94518

object_name: Cross Infection


subject: CHEBI:94518

object_name: no feeling or sensation of skin


subject: CHEBI:94518

object_name: Sensory Loss


subject: DRUGBANK:DB17320

subject_name: Prexigebersen

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17320

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17320

object_name: Solid Neoplasm


subject: DRUGBANK:DB17320

object_name: ovarian carcinoma


subject: DRUGBANK:DB17320

object_name: fallopian tube neoplasm


subject: DRUGBANK:DB17320

object_name: endometrial cancer


subject: DRUGBANK:DB17320

object_name: uterine corpus cancer


subject: DRUGBANK:DB17320

object_name: endometrial carcinoma


subject: DRUGBANK:DB17320

object_name: peritoneum cancer


subject: DRUGBANK:DB05920

subject_name: RTA 744

object_name: neoplastic meningitis


subject: DRUGBANK:DB05920

object_name: brain neoplasm


subject: DRUGBANK:DB05920


subject: DRUGBANK:DB05920


subject: DRUGBANK:DB05920


subject: DRUGBANK:DB05920

object_name: adult lymphoma


subject: DRUGBANK:DB05920

object_name: lymphoma


subject: DRUGBANK:DB05920

object_name: pediatric lymphoma


subject: DRUGBANK:DB05920

object_name: leukemia


subject: DRUGBANK:DB05920

object_name: childhood leukemia


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: ovarian cancer


subject: UNII:6A901E312A

object_name: ovarian neoplasm


subject: UNII:6A901E312A


subject: UMLS:C0962969

subject_name: RAD 001

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UMLS:C1442960

subject_name: Turkey antigen

object_name: Neonatal hyperbilirubinemia


subject: DRUGBANK:DB10575

subject_name: Turkey


subject: PUBCHEM.COMPOUND:134812690

subject_name: bavarostat

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:134812690

object_name: alcohol dependence


subject: PUBCHEM.COMPOUND:134812690

object_name: post-traumatic stress disorder


subject: CHEBI:36796

subject_name: duloxetine

object_name: emotional trauma


subject: UMLS:C1174097

object_name: type 2 diabetes mellitus


subject: UMLS:C1174097

object_name: Diabetes


subject: UMLS:C1174097

object_name: diabetes mellitus


subject: UMLS:C5874014

subject_name: Aspirin EC

object_name: Stage I Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage II Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage IIA Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage IIC Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: UMLS:C5874014

object_name: prostate adenocarcinoma


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: CHEBI:8871

subject_name: Risperidone

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:8871

object_name: delusional disorder


subject: CHEBI:94534

subject_name: olanzapine


subject: UMLS:C2698199

subject_name: Lovaxin-C

object_name: non-small cell lung carcinoma


subject: UMLS:C3884847

subject_name: ma zi ren wan

object_name: Functional constipation


subject: UMLS:C3884847

object_name: digestive system disorder


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Pemphigoid


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C5784840

subject_name: IL-2/Anti-IL-2 Antibody Conjugate SLC-3010

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: chronic thromboembolic pulmonary hypertension


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:32301

subject_name: warfarin potassium


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: hematologic disorder


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Caesarean section


subject: CHEBI:8713

subject_name: Quinapril

object_name: myocardial ischemia


subject: CHEBI:8713

object_name: Family history of ischemic heart disease


subject: MESH:C000728624

object_name: B-cell neoplasm


subject: MESH:C000728624

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4329438


subject: UMLS:C4329438


subject: CHEBI:134677

subject_name: Crisaborole

object_name: Stasis dermatitis


subject: MESH:C000597235

object_name: melanoma


subject: CHEBI:85993

subject_name: Palbociclib

object_name: malignant soft tissue neoplasm


subject: CHEBI:85993

object_name: sarcoma


subject: CHEBI:85993

object_name: adult liposarcoma


subject: CHEBI:85993

object_name: liposarcoma


subject: CHEBI:85993

object_name: pediatric liposarcoma


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: kidney failure


subject: CHEBI:6770

object_name: Renal Failure, CTCAE


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: UMLS:C5706368

subject_name: Anti-B7-H3 Antibody-drug Conjugate HS-20093

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:94686

subject_name: Orlistat

object_name: type 2 diabetes mellitus


subject: CHEBI:94686

object_name: Diabetes


subject: CHEBI:94686

object_name: diabetes mellitus


subject: CHEBI:94686

object_name: obstructive sleep apnea syndrome


subject: CHEBI:6402

subject_name: Leflunomide

object_name: smoldering plasma cell myeloma


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: cystic fibrosis


subject: UNII:2P471X1Z11

object_name: allergic bronchopulmonary aspergillosis


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C4524378

subject_name: Fluorine F 18 Integrin Alpha v Beta 6-targeted Peptide

object_name: lung cancer


subject: UMLS:C4524378

object_name: lung neoplasm


subject: UMLS:C4524378

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C4524378

object_name: non-small cell lung carcinoma


subject: UMLS:C4086994

object_name: Genitourinary Cancer


subject: UMLS:C4086994

object_name: bladder tumor


subject: UMLS:C4086994

object_name: urinary bladder carcinoma


subject: UMLS:C4086994

object_name: urinary bladder cancer


subject: UMLS:C4086994

object_name: childhood bladder carcinoma


subject: UMLS:C4086994

object_name: Neoplasm of the genitourinary tract


subject: PR:000023858

subject_name: small ribosomal subunit protein uS5

object_name: hypertension


subject: UniProtKB:P0A7W1

subject_name: RS5_ECOLI Small ribosomal subunit protein uS5 (sprot)


subject: PR:000017034


subject: UMLS:C1608615

object_name: HIV infection


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage 0 Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage I Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988